Medication-Assisted Treatment (MAT): Everything You Need to Know

Medication-assisted treatment (MAT) is an evidence-based approach that combines specific, FDA-approved medications with counseling and behavioral support to treat substance use disorders, primarily those involving opioids and alcohol. These medications stabilize brain chemistry, reduce cravings, and ease withdrawal, making the psychological and spiritual work of recovery more achievable and leading to better social and health outcomes, including a lower risk of overdose. Although MAT is still widely used, the more precise terms Medications for Opioid Use Disorder (MOUD) and Medications for Alcohol Use Disorder (MAUD) are often preferred to emphasize that medication is a central, rather than merely “assisted,” component of care.

Are you navigating the challenging path of drug and alcohol recovery? You’re not alone. Millions face similar struggles, and thankfully, effective treatments are available. One of the most rigorously studied and effective medical approaches for opioid and alcohol use disorders is medication-assisted treatment. Yet, it remains misunderstood and underused.

If you’re already in drug and alcohol recovery or are considering it, understanding how these treatments work, what they can and cannot do, and how they fit into different visions of sobriety is critical for making informed, empowering choices. 

Understanding Medication-Assisted Treatment in Plain Language

Medication-assisted-treatment, often shortened to MAT, refers to the use of specific, approved medications alongside counseling and other supports to treat substance use disorders, especially opioid and alcohol use disorders. These medications work by easing withdrawal, reducing cravings, and stabilizing brain chemistry so that people can focus on rebuilding their lives rather than fighting constant urges or the physical pain of withdrawal. Decades of research demonstrate that MAT is associated with less illicit drug use, fewer overdoses, lower rates of infectious disease transmission, and better social outcomes such as employment and family stability.

Although “medication-assisted treatment” is still widely used, many clinicians and advocates now prefer terms that name the specific condition being treated. For opioids, you will often see Medications for Opioid Use Disorder (MOUD); for alcohol, Medications for Alcohol Use Disorder (MAUD). The science, however, is clear regardless of terminology: for opioid and alcohol use disorders, addiction pharmacotherapy is not a shortcut or a crutch, but a medically sound, life‑saving component of recovery for many people. For this reason, many modern MAT rehab programs integrate counseling, peer support, and medical care in a unified model rather than treating medication as an optional add‑on.

For people in recovery, it can be helpful to think of sobriety medications the way we think of insulin for diabetes or antidepressants for depression. The medications do not do the psychological and spiritual work of recovery for you, but they can make that work more achievable by calming the storm in your nervous system and reducing the risk that a single lapse turns into a fatal overdose.

Why the Language Is Changing: MAT, MOUD, & MAUD

One of the most common questions today is: What is the difference between MAT and MOUD? Traditionally, MAT meant any treatment approach that combined medication with counseling and behavioral therapies for substance use disorders, especially opioid and alcohol use disorders. Under this older umbrella, the same term, medication-assisted treatment, might be used whether clinicians were treating opioid use disorder or alcohol use disorder, and whether the setting was a methadone clinic, a primary care office, or an inpatient program.

The term MOUD narrows the focus to the medications themselves and to a specific diagnosis, opioid use disorder. MOUD typically refers to three FDA‑approved opioid use disorder medication options: methadone, buprenorphine, and extended‑release naltrexone. These medications act directly on opioid receptors or block them to reduce cravings and protect against relapse and overdose. In contrast, MAUD refers to medications for alcohol use disorder, most commonly naltrexone, acamprosate, and disulfiram.

So why is MAT being renamed to MOUD and MAUD in many professional settings? There are three main reasons:

• Medication as a primary treatment: Experts have become concerned that the phrase “medication‑assisted” implies that medication is merely a supplement rather than a central, evidence-based treatment in its own right.
• Precision: MOUD and MAUD are more precise and help distinguish between opioid‑focused and alcohol‑focused pharmacotherapy, which is important because the medications, evidence base, and risks differ between these disorders.
• Stigma: Language is a powerful driver of stigma. Terms like “opioid substitution therapy” or “replacement therapy” suggest that people are merely swapping one addiction for another, which is not accurate and can deter people from life-saving care.

In practice, you will still see medication-assisted treatment used in program names and insurance documents, especially when programs treat both OUD and AUD. The newer terms emphasize that MOUD recovery and MAUD treatment are rooted in strong evidence and deserve the same respect as other medical treatments. For a person in recovery, the key point is that the label matters far less than the quality, safety, and person‑centeredness of the care you receive.

Medications for Opioid Use Disorder (MOUD)

When people talk about opioid use disorder medication, they are usually referring to three FDA‑approved options: methadone, buprenorphine, and extended‑release naltrexone.

• Methadone: A long-acting full opioid agonist that occupies opioid receptors in a steady, sustained way, preventing withdrawal and reducing cravings.
• Buprenorphine: A partial opioid agonist with a “ceiling effect,” relieving withdrawal and cravings while reducing overdose risk. Available in various forms, including Suboxone and long-acting injectables.
• Extended-release naltrexone (Vivitrol): An opioid antagonist given as a monthly injection, blocking the effects of opioids and reducing cravings.

A large head-to-head trial comparing Suboxone and Vivitrol for MOUD recovery found that buprenorphine-naloxone had better overall outcomes, primarily because more people were able to start and stay on it; nonetheless, among those who successfully initiated extended-release naltrexone, relapse rates were similar.

One of the most frequent questions from people in recovery is: How long do you stay on MOUD for opioid recovery? The strongest evidence suggests that long-term MOUD for opioid addiction through evidence-based MAT programs provides the greatest protection against overdose and relapse.

Medications for Alcohol Use Disorder (MAUD)

While MOUD focuses on opioids, MAUD treatment refers to evidence-based prescribing for alcohol use disorder. The three main FDA-approved medications are disulfiram, naltrexone (oral and injectable), and acamprosate.

• Disulfiram (Antabuse): A deterrent medication that causes unpleasant symptoms if alcohol is consumed.
• Naltrexone: Blocks mu-opioid receptors involved in the rewarding effects of alcohol, reducing cravings and heavy drinking days. Vivitrol is the injectable form, used for both MAUD and MOUD.
• Acamprosate (Campral): Modulates glutamate and GABA in the brain, helping to rebalance systems dysregulated by chronic heavy drinking.

While every medication has side effects, Antabuse is an older drug that is prescribed less and less with so many other treatment options out there. The permanent side effects of disulfiram, while rare, can be irreversible in some patients, so ask your provider for other options before taking Antabuse. If they refuse, perhaps ask for a second opinion as you begin treatment. You want a physician who supports your recovery efforts and is also knowledgeable about more modern approaches to care.

What exactly does medication for alcohol use disorder do? It tries to accomplish three main treatment goals:

• Reduces craving and dampens the reinforcing effects of alcohol
• Stabilizes brain function after long periods of heavy use
• Breaks the cycle of habitual drinking, creating a window for other recovery efforts

Sobriety, Identity, & Recovery While on Medications

A deeply personal question for many people is: Does using MOUD mean I am not fully sober? There is no single answer, because “sobriety” is as much a cultural and spiritual concept as a medical one. Professional organizations explicitly endorse methadone and buprenorphine as the standard of care, and they do not describe properly prescribed MOUD as incompatible with recovery. Indeed, for many people, navigating sobriety with addiction medications has been the key to being present for family, work, and personal growth after years of chaotic use.

You can absolutely do a 12-step program while on MOUD, though you may need to seek out groups or sponsors who are supportive or at least respectful of medication as part of your recovery.

Access, Coverage, and Models of Care

A practical concern for many people is whether medication-assisted treatment is covered by insurance. In many jurisdictions, the answer is increasingly yes. Federal Medicaid policy now requires state plans to cover all FDA‑approved MOUD medications, including methadone, buprenorphine, and naltrexone, as well as associated counseling and behavioral therapies, for eligible beneficiaries with OUD.

In terms of where to receive care, models are evolving. Traditional MAT rehab programs often involve structured outpatient or residential settings where medications are combined with intensive counseling, peer support, and social services. Increasingly, primary care practices, hospital addiction consult services, and telemedicine platforms are providing MOUD and MAUD, making it possible for people to receive treatment in familiar healthcare environments.

For many individuals searching online for “evidence-based MAT programs near me,” look for programs that offer Suboxone and Vivitrol for MOUD recovery and/or outpatient MAUD programs for alcoholism within a reasonable distance.

If you or someone you know is struggling with substance abuse, Mountainside can help. We offer individualized and comprehensive treatment that meets people where they are. Speak with an admissions specialist today to discover your options!